Medications for Primary Hyperoxaluria Type 1
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Primary Hyperoxaluria Type 1.
Found 2 Approved Drugs for Primary Hyperoxaluria Type 1
Oxlumo
Generic Name
Lumasiran
Oxlumo
Generic Name
Lumasiran
Form: Injection
Method of administration: Subcutaneous
FDA approval date: November 23, 2020
OXLUMO is indicated for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients [see Clinical Pharmacology (1.
Rivfloza
Generic Name
Nedosiran
Rivfloza
Generic Name
Nedosiran
Form: Injection
Method of administration: Subcutaneous
FDA approval date: February 19, 2024
RIVFLOZA is indicated to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥30 mL/min.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances